Evidence map›Paper›PMID 31892216›Full record

ArticleInternational journal of molecular sciences2019

Cardiac-Specific Overexpression of Catalytically Inactive Corin Reduces Edema, Contractile Dysfunction, and Death in Mice with Dilated Cardiomyopathy.

Ranjana Tripathi, Ryan D Sullivan, Tai-Hwang M Fan, Aiilyan K Houng, Radhika M Mehta, Guy L Reed, Inna P Gladysheva

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Single-Nucleotide Polymorphisms in the 3' Untranslated Region ofFrontiers in cardiovascular medicine · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ranjana TripathiDepartment of Internal Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
Ryan D SullivanDepartment of Internal Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
Tai-Hwang M FanDepartment of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Aiilyan K HoungDepartment of Internal Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Radhika M MehtaDepartment of Internal Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
Guy L ReedDepartment of Internal Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.
Inna P GladyshevaDepartment of Internal Medicine, University of Arizona College of Medicine-Phoenix, Phoenix, AZ 85004, USA.ORCID 0000-0002-2501-9029
University of Arizona · USUniversity of Tennessee Health Science Center · US

Funding

Corin in Cardiomyopathy and Heart FailureR01HL115036 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI GLADYSHEVA, INNA P · 2012 to 2016
$2.4M
Alpha-2-antiplasmin and Ischemic StrokeR01NS089707 · NINDS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI REED, GUY L · 2015 to 2019
$1.9M
NHLBI NIH HHS R01 HL115036NIH HHS HL115036NIH HHS NS089707NINDS NIH HHS R01 NS089707
6 · The paper itself

Abstract

Humans with dilated cardiomyopathy (DCM) and heart failure (HF) develop low levels of corin, a multi-domain, cardiac-selective serine protease involved in natriuretic peptide cleavage and sodium and water regulation. However, experimental restoration of corin levels markedly attenuates HF progression. To determine whether the beneficial effects of corin in HF require catalytic activity, we engineered cardiac overexpression of an enzymatically inactive corin transgene (corin-Tg(i)). On a wild-type (WT) background, corin-Tg(i) had no evident phenotypic effects. However, in a well-established genetic model of DCM, corin-Tg(i)/DCM mice had increased survival (

Indexed as

AnimalsBiomarkersCardiomyopathy, DilatedEdemaFemaleGlycogen Synthase Kinase 3 betaHeartHeart FailureHumansMaleMiceMice, Inbred C57BLMyocardial ContractionMyocardiumSerine EndopeptidasesBiomarkersCorin protein, mouseGlycogen Synthase Kinase 3 betaSerine Endopeptidasescorindilated cardiomyopathyedemaheart failure

Identifiers

PMID31892216
PMCPMC6981738
OpenAlexW2997343043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.